<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201201138717N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2012-01-26</date_registration>
      <primary_sponsor>Semnan University of Medical Sciences, Semnan, Iran</primary_sponsor>
      <public_title>The effect of patients early mobilization program on the Physical and mental conditions of patients with MI</public_title>
      <acronym></acronym>
      <scientific_title>A survey effect of patients early mobilization program on the Physical and mental conditions of patients with MI hospitalized in CCU</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-02-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/9212</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Acute myocardial infarction.</hc_freetext>
      <i_freetext>Intervention 1: A) Intervention group: the first day, the first stage: In this stage, patients 12-18 hours after admission in hospital, setting from prone position to sitting position and after checking blood pressure and heart rate and lack of hemodynamic disorder and arrhythmia, with direct supervision of researcher, his legs hung bedside for 5 minutes, then return to prone position again. The second stage: at least three hours after the first stage and resting in bed, after checking blood pressure and heart rate and lack of hemodynamic disorder and arrhythmia or incidence of pain, under direct supervision of researcher, after hanging legs and lack of incidence of hemodynamic problems, arrhythmia or pain, patient comes down from the bed and sits on the chair in bedside for five minutes and then return to bed and rest. The second day, the third stage: 24 hours after admission patient, after checking blood pressure, heart rate, lack of hemodynamic disorder and arrhythmia, lack of chest pain and dyspnea, under direct supervision of researcher, patient sits on the chair in bedside for ten minutes and then return to self bed. The fourth stage: at least three hours after the third stage, under direct supervision of researcher, If there is no problem (pain, arrhythmia, hypotension, patient unwillingness), patient standing and walking in bedside for ten minutes and then return to self bed and is monitored. The fifth stage: at least three hours after the fourth stage, after checking vital signs and there is no problem (pain, arrhythmia, hypotension, unwillingness of patients), under direct supervision of researcher, first patient walks in bedside for five minutes and then walks in CCU In the limit of tolerance (range of ten steps to go and ten steps to back) for five minutes and then return to self bed. The third day, the sixth stage: 48 hours after admission, if the patient is no problem. under direct supervision of researcher, first patient walks in bedside for five minutes and then if there is no problem (pain, arrhythmia, hypotension, unwillingness of patients), walks in CCU In the limit of tolerance (range of ten steps to go and ten steps to back) for ten minutes and then return to self bed. The seventh stage: at least three hours after the sixth stage, under direct supervision of researcher, if there is no problem (pain, arrhythmia, hypotension, unwillingness of patients), walks in CCU In the limit of tolerance (range of twenty steps to go and twenty steps to back) for fifteen minutes and then return to self bed. The eighth stage: at least three hours after the previous step, this step is repeated as the seventh stage and if there is no problem, patient is in the state of relative rest. Intervention 2: B) control group&#13;
According to the ward routine, 48 hours after admission, patients are ambulated&#13;
with the help and supervision of researcher.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Reza Asgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of nursing and allied, Semnan University of Medical Sciences, Semnan, Iran</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519819973</zip>
        <telephone>+98 23 1445 3365</telephone>
        <email>asgari@sem-ums.ac.irasgari5000@gmail.com</email>
        <affiliation>Mohammad Reza Asgari</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Reza Asgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of nursing and allied, Semnan University of Medical Sciences, Semnan, Iran</address>
        <city>Semnan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3519819973</zip>
        <telephone>+98 23 1445 3365</telephone>
        <email>asgari@sem-ums.ac.irasgari5000@gmail.com</email>
        <affiliation>Semnan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criterias: (1)  age of participants less than 70 years, (2)  lack of hemodynamic dysfunction (systolic blood pressure Under 100 mmHg and more than 180 mmHg), absence of arrhythmias, and absence of shortness of breath or chest pain before the start of each stage, (3)  lack of atrial ventricular block grade two and three, (4)  lack of cardiac complications which is confirmed by a cardiologist after echocardiography, (5)  lack of acute psychiatric disorders, (6)  lack of motor disorders.&#13;
Exclusion criterias: (1) Patients addicted to narcotic substances, (2) Patients who have a history of cardiopulmonary resuscitation, (3) Patients with myocardial infarction complicated by [hemodynamic disorder, congestive heart failure, signs of carcinogenic shock, continuity of atrial and ventricular arrhythmias, existence of atrial ventricular block grade two and three, pericarditis, pulmonary embolism, stroke or transient ischemic attack, stroke], (4) Patients during stages of the walk have intolerance procedure for three times consecutive, (5) Unwillingness of patients to perform the early mobilization program, (6) Patients who undergoing percutaneous coronary intervention [PCI] and (7) Patients who are treated with thrombolytictherapy.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I21</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute myocardial infarction</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>A) Intervention group: the first day, the first stage: In this stage, patients 12-18 hours after admission in hospital, setting from prone position to sitting position and after checking blood pressure and heart rate and lack of hemodynamic disorder and arrhythmia, with direct supervision of researcher, his legs hung bedside for 5 minutes, then return to prone position again. The second stage: at least three hours after the first stage and resting in bed, after checking blood pressure and heart rate and lack of hemodynamic disorder and arrhythmia or incidence of pain, under direct supervision of researcher, after hanging legs and lack of incidence of hemodynamic problems, arrhythmia or pain, patient comes down from the bed and sits on the chair in bedside for five minutes and then return to bed and rest. The second day, the third stage: 24 hours after admission patient, after checking blood pressure, heart rate, lack of hemodynamic disorder and arrhythmia, lack of chest pain and dyspnea, under direct supervision of researcher, patient sits on the chair in bedside for ten minutes and then return to self bed. The fourth stage: at least three hours after the third stage, under direct supervision of researcher, If there is no problem (pain, arrhythmia, hypotension, patient unwillingness), patient standing and walking in bedside for ten minutes and then return to self bed and is monitored. The fifth stage: at least three hours after the fourth stage, after checking vital signs and there is no problem (pain, arrhythmia, hypotension, unwillingness of patients), under direct supervision of researcher, first patient walks in bedside for five minutes and then walks in CCU In the limit of tolerance (range of ten steps to go and ten steps to back) for five minutes and then return to self bed. The third day, the sixth stage: 48 hours after admission, if the patient is no problem. under direct supervision of researcher, first patient walks in bedside for five minutes and then if there is no problem (pain, arrhythmia, hypotension, unwillingness of patients), walks in CCU In the limit of tolerance (range of ten steps to go and ten steps to back) for ten minutes and then return to self bed. The seventh stage: at least three hours after the sixth stage, under direct supervision of researcher, if there is no problem (pain, arrhythmia, hypotension, unwillingness of patients), walks in CCU In the limit of tolerance (range of twenty steps to go and twenty steps to back) for fifteen minutes and then return to self bed. The eighth stage: at least three hours after the previous step, this step is repeated as the seventh stage and if there is no problem, patient is in the state of relative rest.</i_keyword>
      <i_keyword>B) control group&#13;
According to the ward routine, 48 hours after admission, patients are ambulated&#13;
with the help and supervision of researcher.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Hear Rate. Timepoint: Every 6 hours. Method of measurement: To view the monitor screen.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: Every 6 hours. Method of measurement: According to mmHg by the Pointer manometer.</prim_outcome>
      <prim_outcome>Ejection fraction. Timepoint: 18-12 and 72 hours after MI. Method of measurement: Echocardiography machine.</prim_outcome>
      <prim_outcome>Anxiety. Timepoint: In the first 12-18 and 72 hours after of admission. Method of measurement: By Hospital Anxiety and Depression Scale (HADS).</prim_outcome>
      <prim_outcome>Depression. Timepoint: In the first 12-18 and 72 hours after of admission. Method of measurement: By Hospital Anxiety and Depression Scale (HADS).</prim_outcome>
      <prim_outcome>Duration of stay in hospital. Timepoint: Time of discharge. Method of measurement: According to hours.</prim_outcome>
      <prim_outcome>Frequency of pain. Timepoint: After 72 hours. Method of measurement: Looking at records.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Semnan University of Medical Sciences, Semnan, Iran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-01-16</approval_date>
        <contact_name>Semnan University of Medical Sciences</contact_name>
        <contact_address>Semnan University of Medical Sciences, Semnan, Iran Semnan  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
